ArborGen’s underlying H1 trading performance was robust, although the H2 US selling season has been slower than previously anticipated. Our headline FY21 PBT estimate is reduced by c 1% (or c 30% underlying before COVID-19 employment support monies) with no material change for FY22. An increase in supply of higher-value seedlings in the US remains on track and is expected to drive group earnings higher from FY22.
21 Jan 2021
ArborGen Holdings - US sales slow in H221, positive outlook remains
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
ArborGen Holdings - US sales slow in H221, positive outlook remains
ArborGen Holdings Limited (ARB:NZE) | 0 0 0.0%
- Published:
21 Jan 2021 -
Author:
Toby Thorrington -
Pages:
7
ArborGen’s underlying H1 trading performance was robust, although the H2 US selling season has been slower than previously anticipated. Our headline FY21 PBT estimate is reduced by c 1% (or c 30% underlying before COVID-19 employment support monies) with no material change for FY22. An increase in supply of higher-value seedlings in the US remains on track and is expected to drive group earnings higher from FY22.